FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.
Check out the Communication page for the complete details by clicking the link: Communications
The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about...
On June 13, 2019, the new CTS Laboratory Information System was successfully implemented in Cha...
CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical ...
Celebrate National Blood Donor Month throughout January by inviting eligible individuals to donate b...
CTS will implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The ...
Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA test...